Ligand validation:2V0W

FMN: FLAVIN MONONUCLEOTIDE

FMN is a Ligand Of Interest in 2V0W designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2V0W_FMN_A_1547	84%	15%	0.096	0.957	1.58	2.17	4	9	2	0	100%	1
7PGX_FMN_AAA_618	100%	62%	0.042	0.99	0.77	0.68	1	-	0	0	100%	1
2V1B_FMN_A_1547	94%	7%	0.061	0.961	1.81	2.97	5	15	1	0	100%	1
2V1A_FMN_A_1547	91%	50%	0.082	0.97	0.83	1.1	2	5	0	0	100%	1
5DJT_FMN_A_602	91%	43%	0.081	0.966	1.16	1.04	2	2	0	0	100%	1
2V0U_FMN_A_1547	89%	47%	0.087	0.966	0.97	1.08	1	3	0	0	100%	1
4XHF_FMN_C_300	100%	16%	0.024	0.995	2.46	1.29	11	6	0	0	100%	0.9677
1QXO_FMN_D_4004	100%	27%	0.025	0.993	1.24	1.7	2	15	1	0	100%	1
5LJI_FMN_A_201	100%	27%	0.025	0.995	1.62	1.33	5	5	0	0	100%	1
9DHH_FMN_A_401	100%	35%	0.026	0.994	1.4	1.19	5	5	0	0	100%	1
8J4W_FMN_C_201	100%	43%	0.031	0.992	1.08	1.12	2	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.